Sponsor dell'anno
Ultimo aggiornamento:
25/02/2021
Best view 1024 x 768
Ottimizzato per IE
Pubblicazioni
Elenco completo
TITOLO AUTORI EDITORE ANNO DOSSIER PAGINE LINGUA
A case of pituitary adenoma associated with McCune-Albright syndrome Sakaki S, Yokoyama S, Mamitsuka K, Nakayama M, Goto M, Kuratsu J, Pituitary 1999 1 297-302 en
A follicular cyst during tamoxifen therapy in premenopausal breast cancer woman Terada S, Uchide K, Suzuki N, Akasofu K, Gynecol Obstet Invest 1993 35 62-64 en
A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors Kotlar TJ, Young RH, Albanese C, Crowley WF Jr, Scully RE, Jameson JL, J Clin Endocrinol Metab 1997 82 1020-1026 en
A new constitutively activating mutation of the G, protein alpha subunit-gsp oncogene is found in human pituitary tumours Clementi E, Malgaretti N, Meldolesi J, Taramelli R, Oncogene 1990 5 1059-1061 en
A novel GNASI mutation, R201G, in McCune-Albright syndrome Riminucci M, Fisher LW, Majolagbe A, Corsi A, Lala R, De Sanctis C, Robey PG, Bianco P, J Bone Miner Res 1999 14 1987-1989 en
Abnormalities in G-protein-coupled signal transduction pathways in human disease Spiegel AM, Weinstein LS, Shenker A, J Clin Invest 1993 92 1119-1125 en
Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome Foster CM, Ross Jl, Shawker T, Pescovitz OH, Loriaux DL, Cutler GB Jr, J Clin Endocrinol Metab 1984 5 1161-1165 en
Acromegaly and its treatment in the McCune-Albright syndrome Premawardhana LDKE, Vora JP, Mills R, Scanalon MF, Clin Endocrinol 1992 36 605-608 en
Activating and inactivating mutations in LH receptors Themmen AP, Martens JW, Brunner HG, Mol Cell Endocrinol 1998 145 137-142 en
Activating mutation of Gs alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes Kim IS, Kim ER, Nam HJ, Chin MO, Moon YH, Oh MR, Yeo UC, Song SM, Kim JS, Uhm MR, Beck NS, Jin Dk Horm Res 1999 52 235-240 en
Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS , Frazzatto ET, Mendonca BB, Villares SM, J Clin Endocrinol Metab 1998 83 2074-2078 en
Activating mutations of the stimulatory G protein in the McCune-Albright syndrome Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM, N Engl J Med 1991 325 1688-1695 en
Albright's Hereditary Osteodystrophy L. C. Wilson Journal of Pediatric Endocrinology & Metabolism (JPEM) 2006 Volume 19, Suppl. 2 671-673 en
Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas Vallar L, Spada A, Giannattasio G, Nature 1987 330 566-567 en
Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestaions of Gaucher's diesease Samuel R, Katz K, Papapoulos SE, Yosipovitch Z, Zaizov R, Liberman U, Pediatrics 1994 94 385-389 en
Aminohydroxy-propylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient Varache N, Audran M, Clochon P, Lortholary A, Bouachour G, Alquier P, Basle MF, Clin Rheumatol 1991 10 328-332 en
Aminohydroxypropylidene-bisphosphonate in the treatment of bone lesions in a case of Gaucher's disease type 3 Bembi B, Agosti E, Boehm P, Nassimbeni G, Zanatta M, Vidoni L, Acta Paediatr Scand 1994 83 122-124 en
An activating Gsa mutation in present in fibrous dyspalsia of bone in the McCune-Albright syndrome Shenker A, Weinstein LS, Sweet DE, Spiegel AM, J Clin Endocrinol Metab 1994 79 750-755 en
An animal model of fibrous dysplasia Bianco P, Robey PG, Mol Med Today 1999 5 322-323 en
An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion Malchoff CD, Reardon G, MacGillivary DC, Yanase H, Rogol AD, Malchoff DM, J Clin Endocrinol Metab 1994 78 803-806 en
Righe 20 di 186 Pagine: [  1  ] [ 2  ] [ 3  ] [ 4  ] [ 5  ] [ 6  ] [ 7  ] [ 8  ] [ 9  ] [ 10  ]